ABT Stock Movement Summary Abbott Laboratories (ABT) rebounded following announcements regarding the Exact Sciences acquisition and positive clinical data. Key Facts: - Abbott announced a $21 billion acquisition of Exact Sciences to expand into cancer diagnostics, addressing portfolio challenges in its Nutrition segment. - The company is increasing focus on diabetes and cardiovascular products as part of a strategic repositioning. - Abbott released two-year data from its SUMMIT-MAC trial supporting the safety and effectiveness of its Tendyne transcatheter mitral valve replacement system. - Q4 results fell below Wall Street expectations due to weakness in the Nutrition segment. - Freedom Capital Markets upgraded ABT to Buy from Hold, citing long-term prospects from the Exact Sciences integration expected in Q2 2026. - Multiple analysts adjusted price targets following earnings, with Leerink Partners lowering its target to $119 and Wells Fargo lowering its target to $122.
Read full analysisABT Stock Movement Summary Abbott Laboratories (ABT) rebounded following announcements regarding the Exact Sciences acquisition and positive clinical data. Key Facts: - Abbott announced a $21 billion acquisition of Exact Sciences to expand into cancer diagnostics, addressing portfolio challenges in its Nutrition segment. - The company is increasing focus on diabetes and cardiovascular products as part of a strategic repositioning. - Abbott released two-year data from its SUMMIT-MAC trial supporting the safety and effectiveness of its Tendyne transcatheter mitral valve replacement system. - Q4 results fell below Wall Street expectations due to weakness in the Nutrition segment. - Freedom Capital Markets upgraded ABT to Buy from Hold, citing long-term prospects from the Exact Sciences integration expected in Q2 2026. - Multiple analysts adjusted price targets following earnings, with Leerink Partners lowering its target to $119 and Wells Fargo lowering its target to $122.
Abbott Laboratories (ABT) is a publicly traded company in the Healthcare sector.